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Available online 23 November 2015Dipeptide species are accumulated in the chronic myelogenous leukemia (CML) stem cells [1]. To investigate the
molecular mechanisms of the accumulation of dipeptide species in CML stem cells, we performed transcriptome
sequencing of long-termstemcells, short-term stemcells, progenitor cells fromhealthy control andCML-affected
mice (GSE70031). The transcriptome data revealed that the expression of a dipeptide transporter (solute carrier
family 15,member 2 (SLC15A2))was elevated only in the CML stem cells. This result indicates that dipeptide spe-
cies accumulates in CML stem cells through a dipeptide transporter SLC15A2.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Slc15a2Speciﬁcationsrganism/cell
line/tissueMus musculus/Bone marrowx
quencer or array type Illumina HiSeq 2000
ata format RNA sequencing: raw data (Fastq ﬁles) and processed
data (tab-delimited text ﬁles include RPKM values)
xperimental factors 8 RNA samples for RNA sequencing as follows:
2 samples of normal long-term stem cell
1 sample of normal short-term stem cell
1 sample of KLS− progenitor cell
2 samples of chronic myeloid leukemia long-term stem cell
1 sample of chronic myeloid leukemia short-term stem cell
1 sample of chronic myeloid leukemia KLS− progenitor cellxperimental features Immature KLS+ cells and KLS− progenitor cells were
obtained from healthy control and CML-affected mice by
using FACS Aria III cell sorter.onsent
mple source locationSa1. Direct link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE70031.Biology, Research Institute for
y, 1-2-3 Kasumi, Minami-ku,
).
. This is an open access article under2. Experimental design, materials and methods
2.1. RNA sample preparation and transcriptome sequencing
We isolated the most primitive long-term (LT) stem cells (CD150+-
CD48−CD135−KLS+ cells), short-term (ST) stem cells (CD150−-
CD48−CD135−KLS+ cells), and KLS− progenitor cells from healthy
littermate control and CML-affected mice. Eight different RNA samples
were extracted from two samples of normal LT stem cells, one sample
of normal ST stem cells, one sample of normal KLS− progenitor cells,
two samples of CML LT stem cells, one sample of CML ST stem cells,
and one sample of CML KLS− progenitor cells. Paired-end reads RNA se-
quencingwas performed using IlluminaHiSeq2000 for all RNA samples.
All sequenced reads were trimmed for adaptor sequence, then mapped
tomm9whole genome usingDNAnexus. Reads Per Kilobase of exon per
Megabase of library size (RPKM) were calculated using DNAnexus.
2.2. Differentially expressed genes (DEGs)
We identiﬁed DEGs by comparing expression levels of CML stem
cells with those of three other types of cells (normal stem cells, normal
KLS− progenitor cells, and CML KLS− progenitor cells). Geneswere con-
sidered DEGs if their fold-changewasmore than 2-fold and p-valuewas
less than 0.05. A one-sided two-sample t-test was used to calculate the
p-values. From the analysis, we identiﬁed 528 up- and 238 down-
regulated DEGs in CML stem cells (Fig. 1a). Among up-regulated DEGs,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Differentially expressed genes in chronic myelogenous leukemia (CML) cells. (a) Heat map of up- and down-regulated DEGs in CML stem cells. (b) Slc15a2 expression level. LT, ST,
and KLS− represent long-term stem cell, short-term stem cell, and KLS− progenitor cell, respectively.
58 J. Kim et al. / Genomics Data 7 (2016) 57–59a dipeptide transporter Slc15a2 was highly expressed only in CML stem
cells (Fig. 1b). This represents that high expressed Slc15a2 gene causes
the accumulation of dipeptide species in CML stem cells.
2.3. Gene ontology (GO) analysis
We identiﬁed GO terms enriched in the up- and down-regulated
DEGs of CML stem cells using DAVID functional annotation tool [1],
respectively. GO analysis revealed that the up-regulated DEGs were
associated with GO terms “antigen processing and presentation”,Table 1
Gene ontology (GO) terms associated with the up-regulated differentially expressed genes in c
Term p-value Genes
GO:0019882~antigen processing and presentation 1.16E-06 H2-EA, H2-Q10, MILL2,
1500011B03RIK, H2-DM
GO:0007156~homophilic cell adhesion 5.45E-04 DSG4, CADM1, FAT2, PC
GO:0007155~cell adhesion 5.48E-04 CADM1, PKHD1, CLDN5,
INPPL1, PCDH9, PCDHGB
GO:0050953~sensory perception of light stimulus 0.0033091 TULP1, PDE6B, EPAS1, A
GO:0007167~enzyme linked receptor protein
signaling pathway
0.0067592 FGFR2, EGFR, EFNA1, LT
TGFA, PDGFC
GO:0007169~transmembrane receptor protein
tyrosine kinase signaling pathway
0.0071313 IGSF10, EGFR, FGFR2, EP
GO:0002474~antigen processing and presentation
of peptide antigen via MHC class I
0.0074334 H2-Q10, GM8909, H2-T
Table 2
Gene ontology (GO) terms associated with the down-regulated differentially expressed genes
Term P-value Genes
GO:0006334~nucleosome assembly 7.60E-08 HIST1H2AB, H
HIST3H2A, HIS
GO:0030036~actin cytoskeleton organization 3.88E-04 CNN3, MYBPC
GO:0006955~immune response 0.0045826 MASP2, IL1RN
GO:0031667~response to nutrient levels 0.0077562 UGT1A2, PCSK“cell adhesion”, “sensory perception of light stimulus”, and “enzyme
linked receptor protein signaling pathway” (Table 1). The down-
regulated DEGs were associated with GO terms “nucleosome assem-
bly”, “actin cytoskeleton organization”, “immune response”, and “re-
sponse to nutrient levels” (Table 2).
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